CompletedPhase 2NCT01170936
Ilaris® in Urticarial Vasculitis - Investigation of Treatment Responses
Studying Hypocomplementemic urticarial vasculitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Charite University, Berlin, Germany
- Principal Investigator
- Marcus Maurer, MD, MDCharite University, Berlin, Germany
- Intervention
- canakinumab(drug)
- Enrollment
- 10 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2010 – 2011
Study locations (1)
- Charité-Universitätsmedizin Berlin, Berlin, State of Berlin, Germany
Collaborators
Novartis Pharmaceuticals
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01170936 on ClinicalTrials.gov